Цитирование
Natchanon Kulsumritpon. Short-Course Potent P2Y12 Inhibitor–Based DAPT Versus Clopidogrel-Based DAPT After PCI: A Propensity-Matched Real-World Study. // Cardiovascular Drugs and Therapy. – 2025. – DOI: 10.1007/s10557-025-07750-w. – URL: https://doi.org/10.1007/s10557-025-07750-w
Natchanon Kulsumritpon (2025). Short-Course Potent P2Y12 Inhibitor–Based DAPT Versus Clopidogrel-Based DAPT After PCI: A Propensity-Matched Real-World Study. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-025-07750-w
Natchanon Kulsumritpon. “Short-Course Potent P2Y12 Inhibitor–Based DAPT Versus Clopidogrel-Based DAPT After PCI: A Propensity-Matched Real-World Study.” Cardiovascular Drugs and Therapy, 2025. doi:10.1007/s10557-025-07750-w.
@article{Kulsumritpon2025,
title = {Short-Course Potent P2Y12 Inhibitor–Based DAPT Versus Clopidogrel-Based DAPT After PCI: A Propensity-Matched Real-World Study},
author = {Kulsumritpon, Natchanon},
journal = {Cardiovascular Drugs and Therapy},
year = {2025},
doi = {10.1007/s10557-025-07750-w},
url = {https://doi.org/10.1007/s10557-025-07750-w}
}